Dendritic Cell Based Therapy of Renal Cell Carcinoma

針對症狀 Advanced Renal Cell Carcinoma
臨床試驗編號 NCT00197860
臨床階段 Phase I/II
臨床試驗位址 Department of Oncology, Copenhagen University Hospital, Herlev
目前研究進度 This study has been completed.
試驗開始日期 September 20, 2005
試驗開始日期 November 23, 2011

The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with peptides or tumor lysate in combination with adjuvant cytokines can induce a measurable immune response in patients with metastatic renal cell carcinoma, and to evaluate the clinical effect (objective response rate) of the vaccination regime."